1. Home
  2. NEN vs NKTR Comparison

NEN vs NKTR Comparison

Compare NEN & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership

NEN

New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership

N/A

Current Price

$52.00

Market Cap

197.0M

Sector

Real Estate

ML Signal

N/A

Logo Nektar Therapeutics

NKTR

Nektar Therapeutics

N/A

Current Price

$46.51

Market Cap

2.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NEN
NKTR
Founded
1977
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Building operators
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
197.0M
2.2B
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
NEN
NKTR
Price
$52.00
$46.51
Analyst Decision
Strong Buy
Analyst Count
0
12
Target Price
N/A
★ $141.40
AVG Volume (30 Days)
862.0
★ 1.4M
Earning Date
11-06-2026
11-05-2026
Dividend Yield
★ 3.27%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
$89,196,544.00
★ $307,711,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$36.10
P/E Ratio
$19.68
★ N/A
Revenue Growth
10.76
★ 86.00
52 Week Low
$50.00
$33.40
52 Week High
$73.50
$109.00

Technical Indicators

Market Signals
Indicator
NEN
NKTR
Relative Strength Index (RSI) 44.86 31.27
Support Level N/A $54.13
Resistance Level $57.00 $76.63
Average True Range (ATR) 0.85 3.61
MACD -0.16 -0.92
Stochastic Oscillator 33.33 7.64

Price Performance

Historical Comparison
NEN
NKTR

About NEN New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership

New England Realty Associates LP is engaged in the business of acquiring, developing, holding for investment, operating, and selling real estate. The Partnership owns and operates various residential apartments, condominium units, and commercial properties located in Massachusetts and New Hampshire. The company generates revenue from rental income from residential and commercial properties recognized over the term of the related lease. The long-term goals of the Partnership are to manage, rent, and improve its properties and to acquire additional properties with income and capital appreciation potential as suitable opportunities arise.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.

Share on Social Networks: